Research
The Defense Advanced Research Projects Agency (DARPA) recently launched a space-based manufacturing exploration initiative targeting future space structure production on-orbit without volume constraints.
The agency's Novel Orbital Moon Manufacturing, Materials, and Mass Efficient Design (NOM4D)... Read More »
In a study conducted on non-human primates, Soligenix, Inc.’s CiVax COVID-19 booster vaccine candidate produced increased neutralizing antibody responses to SARS-CoV-2 and its Delta Omicron variants.
The results, released last week, showed the heat-stable vaccine candidate generated as much... Read More »
The more detail provided on a disease, the better for doctors to pursue proper treatment, and in that regard, Roche and its subsidiary TIB Molbiol announced this week that they have tests capable of identifying between the Delta variant and various Omicron subvariants of SARS-CoV-2.
These tests... Read More »
With an eye on potential vaccine development, the Coalition for Epidemic Preparedness Innovations (CEPI) announced this week that it will expand its partnership with Bangladesh’s icddr,b for a study into survivors of the deadly Nipah virus.
This support will take the form of nearly $1 million... Read More »
The Director of National Intelligence (DNI) research and development arm, the Intelligence Advanced Research Projects Activity (IARPA), has initiated the Biometric Recognition & Identification at Altitude and Range (BRIAR) program.
“National security technologies must accurately and reliably... Read More »
The U.S. Department of Homeland Security (DHS) recently released a report that seeks to assess efforts to maximize preventing, detecting, and responding to potential domestic violent extremism threats.
“Every day, the more than 250,000 dedicated public servants at DHS work to ensure the safety... Read More »
Dosing officially began last week in a Phase 2 trial of Moderna’s COVID-19 Omicron variant-specific, bivalent booster vaccine candidate.
Known currently as mRNA-1273.214, the candidate combines another Omicron booster candidate with Moderna’s official COVID-19 vaccine, mRNA-1273.
"We are... Read More »
In a new report released this week, the nonprofit Trust for America’s Health (TFAH) called out gaps in states’ emergency response capabilities and advocated for urgent investment in a new public health system.
The report, Ready or Not 2022: Protecting the Public’s Health from Diseases,... Read More »
The Auburn University College of Veterinary Medicine (AUCVM) has been awarded a five-year, $24 million Department of Homeland Security (DHS) Science and Technology Directorate (S&T) canine development contract.
“Canines are an important tool in support of the S&T mission to prevent and respond... Read More »
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) began a clinical trial this week investigating rare but potentially serious systemic allergic reactions to COVID-19 mRNA vaccines.
“People who experienced an allergic reaction after receiving a COVID-19 mRNA... Read More »
Efforts are underway to study the possibilities of oral smallpox treatment TPOXX as a post-exposure prophylactic (PEP), with the announcement of clinical trials by SIGA Technologies, Inc. last week.
These trials will support a U.S. Food and Drug Administration (FDA) label expansion for the drug,... Read More »
The primary goal of the international COVID-19 Technology Access Pool (C-TAP) to facilitate access to COVID-19 health products received a major boost last week with an offer from the U.S. National Institutes of Health (NIH) for several related technologies.
These offers would allow potential... Read More »
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) recently released a Request for Information (RFI) to obtain first responder new and emerging technologies.
First responders would experiment with and test the technological offerings during the multi-day... Read More »
Global aerospace company Boeing is detailing the construction of the latest Wideband Global SATCOM (WGS) satellite system version, highlighting advanced techniques effectively integrating commercial technology.
"We're moving at record-breaking speed to deliver the unmatched resilience,... Read More »
The Biomedical Advanced Research and Development Authority (BARDA) will continue long-standing partnerships with GlaxoSmithKline (GSK), Sanofi, and Seqirus to build up medical countermeasures to influenza pandemics and other public health emergencies.
For years, these partnerships and other... Read More »
With test data showing their COVID-19 vaccine’s capabilities to fight COVI-19 in regular or booster form, Sanofi and GSK announced this week that they intend to submit data as the foundation of regulatory authorization requests.
The Sanofi-GSK offering is a refrigerator temperature-stable,... Read More »
Nuclear Threat Initiative (NTI) and Munich Security Conference (MSC) personnel are espousing the benefits of a recently convened tabletop exercise to reduce high-consequence biological threats.
The effort involved uniting senior leaders from across government, industry, and civil society to... Read More »
Following an endorsement from the independent Data and Safety Monitoring Board this week, Moderna, Inc. officially began the third phase of trials for its mRNA Respiratory Syncytial Virus (RSC) vaccine candidate this week.
The safety greenlight was based on preliminary Phase 2 safety and... Read More »
A virtual event organized by the Coalition for Epidemic Preparedness Innovations (CEPI), the Johns Hopkins Center for Health Security, and the German Federal Ministry of Education and Research last week pulled in government officials and technical experts to address the best means of accelerating... Read More »
The ReVector program – an anti-mosquito Defense Advanced Research Projects Agency (DARPA) creation undertaken at Stanford University – entered its next research phase this month, advancing to animal testing.
“Phase 1 of the program focused on identifying microbial or metabolic targets... Read More »
A group of Republican legislators recently forwarded correspondence to President Joe Biden, seeking clarity on re-imposing limits on ground-based missiles in Europe and the Indo-Pacific.
U.S. Reps. Mike Gallagher (R-WI), Mike Rogers (R-AL), Michael McCaul (R-TX), Michael Turner (R-OH), Elise... Read More »
The National Institutes of Health (NIH) last week announced the allocation of $4.5 million across three grant awards to create collaborative research centers in the United States, focusing specifically on investigating treatments and vaccines specifically related to Valley Fever.
These centers... Read More »
Years into a global pandemic, the Access to COVID-19 Tools (ACT) Accelerator and affiliated world leaders have called for fair, shared-based financing of approximately $23 billion in 2022 to overcome inequalities in medical access, scale-up countermeasure efforts, and end the COVID-19... Read More »
The U.S. Department of Homeland Security (DHS) Small Business Innovation Research (SBIR) Program is seeking information regarding building collapse search and rescue technologies.
The DHS Science and Technology Directorate (S&T) administered SBIR Program has issued an Other Agency Technology... Read More »
Phase 2 testing of a Lyme disease vaccine candidate, VLA15, produced strong immune responses, according to the newest data from Valneva SE and Pfizer inc, prompting preparations for a Phase 3 study in the third quarter of 2022.
The VLA15-221 trial produced stronger responses in adult... Read More »
The Office of Justice Programs’ (OJP) National Institute of Justice (NIJ) has released study findings regarding traits of persons who engaged in mass shootings between 1966 and 2019.
“This study — one of the most extensive assessments of mass violence to date—reveals a deeply unsettling... Read More »
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) released a new Pandemic Preparedness Plan this week, directing its research efforts toward identifying pathogens with potential for significant spread among humans and those already known to be major threats.
Informed by a... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) awarded more than $4.5 million in total awards this week to support research into valley fever being conducted by the Universities of California-San Francisco, California-Los Angeles, and Texas-San Antonio.
That money will be... Read More »
The University of Maryland (UMD) has secured a Department of Defense (DOD) award totaling nearly $4 million to support data collection efforts on terrorism-related projects and other asymmetric threats.
The DOD would fund data collection on several projects that include the Study of Terrorism... Read More »
Citing data from six preclinical studies, Merck and Ridgeback Biotherapeutics last week announced that their oral antiviral COVID-19 medicine, molnupiravir, maintained efficacy against the widespread Omicron variant.
These in vitro lab studies were independently organized and conducted by... Read More »
In a letter written to the U.S. Office of Science and Technology Policy (OSTP) and the National Science Foundation (NSF), a bipartisan collection of senators and representatives last week urged continued pursuit of artificial intelligence development, albeit with special care to ethics and... Read More »
In a letter dispatched to Army Secretary Christine Wormuth last week, U.S. Senate Majority Leader Charles Schumer, U.S. Sen. Kirsten Gillibrand, along with U.S. Reps Brian Higgins and Joseph Morelle, urged the development of new cameras to boost military situational awareness.
Specifically, they... Read More »
Results of a multinational, Phase 3 National Institute of Allergy and Infectious Diseases (NIAID)-funded trial last week showed that combining remdesivir with anti-coronavirus hyperimmune intravenous immunoglobulin (HIVIG) fails to do more for COVID-19 hospitalized adults than remdesivir... Read More »
Moderna, Inc. dosed the first participant this week for its Phase 2 study of a COVID-19 booster vaccine tailored to the omicron variant, mRNA-1273.529, kicking off a two cohort trial that will span the United States.
In all, approximately 300 participants will be enrolled in each cohort. One... Read More »
Drawing from a $200 million program meant to stimulate the development of vaccines with broad betacoronavirus protection, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a $16.9 million award this week for development efforts by BioNet.
BioNet, a French-Thai vaccine... Read More »
